Stem cells are cells with the potential to develop into many different types of cells in the body. They serve as a repair system for the body. There are two main types of stem cells: embryonic stem cells and adult stem cells.
Doctors and scientists are excited about stem cells because they have potential in many different areas of health and medical research. Studying stem cells may help explain how serious conditions such as birth defects and cancer come about. Stem cells may one day be used to make cells and tissues for therapy of many diseases, including Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes and arthritis.
Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.\nAjith TA, Jose N, Janardhanan KK.\nJ Exp Clin Cancer Res. 2002 Jun;21(2):213-7.\nPMID: 12148580
Mortality and cancer incidence in cohorts of Swedish fishermen and fishermen's wives: updated findings.\nMikoczy Z, Rylander L.\nChemosphere. 2009 Feb;74(7):938-43. Epub 2008 Nov 28.\nPMID: 19041115
Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM.
Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Int J Cancer. 2007 Jan 17; [Epub ahead of print]
PMID: 17230508 [PubMed - as supplied
Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM.
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1.
PMID
Singh RP, Agarwal R.
Prostate cancer chemoprevention by silibinin: bench to bedside.
Mol Carcinog. 2006 Jun;45(6):436-42. Review.
PMID: 16637061 [PubMed - indexed for MEDLINE]
Singh RP, Agarwal R.
Prostate cancer prevention by silibinin.
Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review.
PMID: 14965263 [PubMed - indexed for MEDLINE]
Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J, Newman RA.
Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Effects on 12-LOX and Rb Protein Phosphorylation.
Cancer Biol Ther. 2007 Feb 25;6(2) [Epub ahead of pr
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.
P R Health Sci J. 2005 Dec;24(4):269-76.
PMID: 16570523
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun;23(2):115-8.\nPMID: 15377059
Holick MF.
Vitamin D: its role in cancer prevention and treatment.
Prog Biophys Mol Biol. 2006 Sep;92(1):49-59. Epub 2006 Mar 10. Review.
PMID: 16566961 [PubMed - indexed for MEDLINE]
Grant WB, Garland CF, Gorham ED.
An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.
Recent Results Cancer Res. 2007;174:225-34.
PMID: 17302200 [PubMed - in process]
Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells.
Eur J Cancer Prev. 2006 Aug;15(4):353-61.
PMID: 16835506 [PubMed - indexed fo